January 22, 2017 11:32 AM ET

Biotechnology

Company Overview of Karyopharm Therapeutics Inc.

Executive Profile

Mansoor Raza Mirza M.D.

Clinical Consultant, Director and Member of Scientific Advisory Board, Karyopharm Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 3 different industries.

See Board Relationships
55$479,498

Background

Dr. Mansoor Raza Mirza, M.D. serves as the Chief Oncologist at the Department of Oncology, Rigshopitalet—the Copenhagen University Hospital, Denmark. Dr. Mirza has also been the Chief Oncologist of The Finsen Centre, Copenhagen University Hospital, Denmark since 2008. He has been Clinical Consultant/Scientific Consultant of Karyopharm Therapeutics, Inc. since 2010. Dr. Mirza is both a medical and radiation oncologist, with a primary focus in non-surgical treatment of ...

Corporate Headquarters

85 Wells Avenue
Newton, Massachusetts 02459

United States

Phone: 617-658-0600
Fax: --

Board Members Memberships

Director
2010-Present
Clinical Consultant, Director and Member of Scientific Advisory Board
2015-Present
Director

Education

MD
Pirogov State Medical Institute
Master's Degree
University of Southern Denmark

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$303,910
Total Calculated Compensation$479,498
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Karyopharm Therapeutics Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.